ArticleMolecular oncology2022

Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies.

Katrine Melvold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.